Ultrasound-guided Percutaneous Electrolysis in Female Soccer With Soleus Injury

November 29, 2021 updated by: Blanca de la Cruz Torres, University of Seville

Clinical Application of Percutaneous Electrolysis in Female Soccer

This study evaluates if the physiotherapy treatment based on combination of therapeutic exercise program and ultrasound-guided PNE on chronic soleous injuries may cause changes in pain, dorsal flexion of the ankle and muscle fatigue in female dance

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
      • Seville, Spain
        • University of Seville

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • older than 18 years
  • having a soleus muscle injury
  • chronic injury (> 3 meses)
  • pain at stretch > 3 points measured by NRS

Exclusion Criteria:

  • belenophobia
  • other accuse injury
  • lumbar back pathology

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group
Participants will receive EPM and they will perform exercise program during 1 month.
Other: Invasive treatment and exercise therapy
The subjects of experimental group will perform therapeutic exercise program and they will be receive Percutaneous Electrolysis therapy and the subjects of experimental group will perform the same exercise program and they will be receive only needling puncture
Experimental: Control group
Participants will receive needling puncture and they will perform exercise program during 1 month.
Other: Invasive treatment and exercise therapy
The subjects of experimental group will perform therapeutic exercise program and they will be receive Percutaneous Electrolysis therapy and the subjects of experimental group will perform the same exercise program and they will be receive only needling puncture

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain at palpation
Time Frame: From baseline measurement up to one month
measured by numeric rate scale (0 no pain; 10 worst pain)
From baseline measurement up to one month
Pain at stretch
Time Frame: From baseline measurement up to one month
measured by numeric rate scale (0 no pain; 10 worst pain)
From baseline measurement up to one month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ankle dorsiflexion
Time Frame: From baseline measurement up to one month
range of motion measured by goniometer (grade)
From baseline measurement up to one month
muscle fatigue
Time Frame: From baseline measurement up to one month
measured by heel test: raise until muscle fatigue (repetitions)
From baseline measurement up to one month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Seville

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 2, 2021

Primary Completion (Actual)

November 1, 2021

Study Completion (Actual)

November 30, 2021

Study Registration Dates

First Submitted

August 20, 2021

First Submitted That Met QC Criteria

August 26, 2021

First Posted (Actual)

September 1, 2021

Study Record Updates

Last Update Posted (Actual)

November 30, 2021

Last Update Submitted That Met QC Criteria

November 29, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Female Soccer

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe